PT Sarana Meditama Metropolitan Tbk (SAME.JK)
IDR 290.0
(-1.36%)
IDR 290.0
(-1.36%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 393.56 Billion IDR | -11.33% |
| 2022 | 443.85 Billion IDR | 28.13% |
| 2021 | 346.41 Billion IDR | 55.07% |
| 2020 | 223.39 Billion IDR | 7.54% |
| 2019 | 207.73 Billion IDR | -18.74% |
| 2018 | 255.64 Billion IDR | 25.72% |
| 2017 | 203.35 Billion IDR | -4.09% |
| 2016 | 212.03 Billion IDR | 52.55% |
| 2015 | 138.99 Billion IDR | 22.81% |
| 2014 | 113.17 Billion IDR | 23.36% |
| 2013 | 91.73 Billion IDR | 28.1% |
| 2012 | 71.61 Billion IDR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 83.87 Billion IDR | -29.54% |
| 2024 Q1 | 119.03 Billion IDR | 19.56% |
| 2024 Q3 | 91.57 Billion IDR | 9.18% |
| 2023 Q1 | 123.38 Billion IDR | 9.94% |
| 2023 Q4 | 99.56 Billion IDR | -23.58% |
| 2023 Q3 | 130.28 Billion IDR | 8.28% |
| 2023 Q2 | 120.31 Billion IDR | -2.49% |
| 2023 FY | 393.56 Billion IDR | -11.33% |
| 2022 Q3 | 113.03 Billion IDR | 3.91% |
| 2022 Q4 | 112.23 Billion IDR | -0.71% |
| 2022 FY | 443.85 Billion IDR | 28.13% |
| 2022 Q1 | 109.8 Billion IDR | 9.1% |
| 2022 Q2 | 108.77 Billion IDR | -0.94% |
| 2021 Q2 | 54.32 Billion IDR | 9.44% |
| 2021 Q3 | 141.8 Billion IDR | 161.03% |
| 2021 Q4 | 100.65 Billion IDR | -29.02% |
| 2021 FY | 346.41 Billion IDR | 55.07% |
| 2021 Q1 | 49.63 Billion IDR | -37.92% |
| 2020 FY | 223.39 Billion IDR | 7.54% |
| 2020 Q1 | 50.65 Billion IDR | -3.36% |
| 2020 Q2 | 41.91 Billion IDR | -17.25% |
| 2020 Q3 | 50.85 Billion IDR | 21.31% |
| 2020 Q4 | 79.96 Billion IDR | 57.25% |
| 2019 Q1 | 81.26 Billion IDR | 5.91% |
| 2019 FY | 207.73 Billion IDR | -18.74% |
| 2019 Q4 | 52.42 Billion IDR | 1513.29% |
| 2019 Q3 | 3.24 Billion IDR | -95.41% |
| 2019 Q2 | 70.79 Billion IDR | -12.88% |
| 2018 Q3 | 59.5 Billion IDR | -3.48% |
| 2018 FY | 255.64 Billion IDR | 25.72% |
| 2018 Q1 | 57.75 Billion IDR | -2.18% |
| 2018 Q2 | 61.65 Billion IDR | 6.74% |
| 2018 Q4 | 76.72 Billion IDR | 28.95% |
| 2017 FY | 203.35 Billion IDR | -4.09% |
| 2017 Q1 | 45.78 Billion IDR | -39.1% |
| 2017 Q2 | 48.49 Billion IDR | 5.92% |
| 2017 Q3 | 50.01 Billion IDR | 3.13% |
| 2017 Q4 | 59.04 Billion IDR | 18.05% |
| 2016 Q1 | 38.84 Billion IDR | -7.42% |
| 2016 FY | 212.03 Billion IDR | 52.55% |
| 2016 Q4 | 75.18 Billion IDR | 61.47% |
| 2016 Q3 | 46.56 Billion IDR | -9.48% |
| 2016 Q2 | 51.44 Billion IDR | 32.43% |
| 2015 Q2 | 35.26 Billion IDR | 17.16% |
| 2015 Q1 | 30.09 Billion IDR | -9.52% |
| 2015 FY | 138.99 Billion IDR | 22.81% |
| 2015 Q4 | 41.95 Billion IDR | 32.46% |
| 2015 Q3 | 31.67 Billion IDR | -10.17% |
| 2014 Q2 | 28.35 Billion IDR | 14.47% |
| 2014 FY | 113.17 Billion IDR | 23.36% |
| 2014 Q4 | 33.26 Billion IDR | 24.17% |
| 2014 Q1 | 24.76 Billion IDR | 1.9% |
| 2014 Q3 | 26.79 Billion IDR | -5.5% |
| 2013 Q1 | 19.17 Billion IDR | 17.95% |
| 2013 Q3 | 24.05 Billion IDR | 0.24% |
| 2013 Q4 | 24.3 Billion IDR | 1.04% |
| 2013 FY | 91.73 Billion IDR | 28.1% |
| 2013 Q2 | 23.99 Billion IDR | 25.18% |
| 2012 FY | 71.61 Billion IDR | 0.0% |
| 2012 Q4 | 16.25 Billion IDR | -13.87% |
| 2012 Q3 | 18.87 Billion IDR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| PT Bundamedik Tbk | 463.16 Billion IDR | 15.028% |
| PT Metro Healthcare Indonesia Tbk | 125.19 Billion IDR | -214.362% |
| PT Medikaloka Hermina Tbk | 1043.54 Billion IDR | 62.286% |
| PT Mitra Keluarga Karyasehat Tbk | 783.59 Billion IDR | 49.774% |
| PT Murni Sadar Tbk | 224.61 Billion IDR | -75.22% |
| PT Famon Awal Bros Sedaya Tbk | 293.68 Billion IDR | -34.011% |
| PT Royal Prima Tbk | 75.23 Billion IDR | -423.102% |
| PT Kedoya Adyaraya Tbk | 105.27 Billion IDR | -273.86% |
| PT Siloam International Hospitals Tbk | 2519.46 Billion IDR | 84.379% |
| PT Sejahteraraya Anugrahjaya Tbk | 583.07 Billion IDR | 32.502% |